Knownwell Successfully Closes $2 Million in Pre-Seed Funding

Knownwell, a company specializing in primary care and metabolic health, announced on Wednesday that it has secured $20 million in Series A financing. Simultaneously, the company has introduced a new program focused on adolescent metabolic health.

Headquartered in Boston, Knownwell provides virtual support to patients in Massachusetts, Rhode Island, and New Hampshire, along with in-person care at its clinic located just outside Boston. The company accepts various insurance plans, including commercial, Medicare, and Medicaid. Knownwell’s services encompass weight-inclusive primary care, where obesity treatment is integrated into primary care, as well as metabolic health services. Patients have access to support from registered dietitians for nutrition, behavioral health services, remote patient monitoring, health coaching, and a movement program. Additionally, the company prescribes GLP-1s when deemed appropriate.

Brooke Boyarsky-Pratt, CEO and co-founder of Knownwell, emphasized the company’s core beliefs during an interview. Firstly, the understanding that obesity is a chronic, lifelong disease that is treatable but requires lifelong management. Secondly, the belief that patients deserve a healthcare home, irrespective of whether they choose to address their weight.

The $20 million Series A funding round was led by A16Z, with participation from Flare Capital Partners. Knownwell has raised a total of $24.5 million. A16Z’s decision to invest in Knownwell was driven by the recognized need for increased support in the realm of obesity care. With the newly acquired funding, Knownwell plans to expand its telehealth and in-person offerings to cover more geographical areas. Additionally, the company intends to invest in its technology and establish partnerships with pharmaceutical companies for clinical trials.